Rat lymph chylomicrons were treated with Pronase resulting in particles completely devoid of surface apoproteins. On re-incubation with serum, the Pronase-treated chylomicrons re-acquired, by transfer from other lipoproteins, all apoproteins except apoprotein B, which is water-insoluble and non-transferable. When two groups of rats were injected with PHicholesterol-labelled control or Pronase-treated chylomicrons, radioactivity was incorporated into the livers of both groups at similar rates. It is concluded that the remnants of the control and Pronase-treated chylomicrons formed in the vascular space were recognized and taken up by liver cells by a process that does not require apoprotein B.
Soon after chylomicrons are released into the circulation from the intestine, they are partially degraded by lipoprotein lipase present on the endothelial surface of the skeletal muscle and adipose tissue (Borensztajn, 1979) . This partial degradation results in the formation of remnants that, compared with the intact chylomicrons, are smaller particles with a much-reduced content of triacylglycerol, phospholipids and apoproteins C and A. Much of the cholesteryl ester and apoprotein E, and all the apoprotein B, is retained (Mj0s et al., 1975; Tall et al., 1979) . Remnants are rapidly removed from circulation by the liver by a process that involves the binding of the particle to receptors on the liver cell surface, followed by internalization of the whole remnant by the cell (Sherrill & Dietschy, 1978; Cooper & Yu, 1978) . The identity of the components on the surface of remnant particles that are recognized by, and bind to, the cell receptors has been the subject of several recent investigations. Liver cells have been shown to possess receptors capable of binding apoprotein E-carrying lipoproteins (Windler et al., 1980) , and convincing evidence has been presented showing that apoprotein E on the surface of remnants participates in the hepatic recognition and uptake of these particles (Sherrill et al., 1980) . Liver cells possess, in addition, receptors capable of binding apoprotein B-carrying lipoproteins (Kovanen et al., 1979; Windler et al., 1980) (Elovson et al., 1981; Wu & Windmueller, 1981; Sparks & Marsh, 1981 200 ,ug of radioactive cholesterol. To obtain liver samples, rats were re-anaesthetized at specified times, and the livers were perfused through the portal vein with Krebs-Ringer bicarbonate buffer, pH 7.4, at 37°C for 1 min, to remove chylomicrons that might have been trapped in the sinusoidal spaces. Liver samples were extracted with chloroform/methanol (2:1, v/v) for the determination of radioactivity as previously described . Otherprocedures Chylomicron protein was determined by the method of Lowry et al. (1951) , triacylglycerols by the method of Fletcher (1968) and cholesterol by the method of Abell et al. (1951) .
Results

Preparation ofchylomicrons devoid ofapoprotein B
One of the characteristics of apoprotein B, not shared with any other apoprotein, is its inability to transfer among lipoproteins (Smith et al., 1978) . We took advantage of this property to prepare rat lymph chylomicrons specifically devoid of apoprotein B. To this end we employed a previously described procedure (Lukens & Borensztajn, 1978) . Chylomicrons are first stripped of their surface apoproteins by proteolysis and then, on incubation with HD lipoprotein or serum, they re-acquire their full complement of transferable apoproteins. In our original report (Lukens & Borensztajn, 1978) the apoprotein profile of the chylomicrons was determined by tetramethylurea/polyacrylamide-gel electrophoresis. Since apoprotein B, unlike all other chylomicron apoproteins, is not soluble in tetramethylurea, its fate, after exposure to a proteolytic enzyme, was not ascertained. In the present study we used sodium dodecyl sulphate/polyacrylamidegel electrophoresis to separate the chylomicron apoproteins. The results obtained are shown in Fig.  1 . Intact rat lymph chylomicrons (gel a) were exposed to Pronase, which completely degraded the tetramethylurea-soluble apoproteins (apoproteins A, E and C) as well as apoprotein B (gel b). When chylomicrons stripped of their apoproteins were incubated with serum, they re-acquired all the transferable apoproteins but not apoprotein B (gel c). (Lukens & Borensztajn, 1978) . When these apoprotein-stripped chylomicrons re-acquire apoprotein C-II, together with the other tetramethylurea-soluble apoproteins by transfer from serum lipoproteins, their capacity to act as substrate for lipoprotein lipase is completely restored (Lukens & Borensztajn, 1978 (Borensztajn & Kotlar, 1981) , was measured at 5, 10 and 15min. It is apparent that at all three time intervals the radioactivity incorporated into the livers of both groups of animals was similar.
Discussion
The results of the present study extend previous Vol. 204 findings that chylomicrons can be stripped of all their surface apoproteins by means of proteolytic digestion (Lukens & Borensztajn, 1978) . These apoprotein-free chylomicrons can readily re-acquire their full complement of apoproteins, except, as shown in the present study, apoprotein B (Fig. 1) . The reconstituted apoprotein B-free chylomicrons cannot be differentiated from control chylomicrons with respect to their capacity to act as substrate for lipoprotein lipase, solubilized or endothelium-bound (Lukens & Borensztajn, 1978) . It is reasonable to assume, therefore, that when apoprotein-free chylomicrons are injected intravenously into rats, they acquire the soluble apoproteins and that apoprotein B-free remnants are formed at rates similar to those of control chylomicrons. (Krishnaiah et al., 1980 (Wu & Windmueller, 1981) . Studies with rats injected with proteinlabelled triacylglycerol-rich lipoproteins carrying both apoprotein B variants have shown that the apoprotein B1 has a significantly shorter half-life in the plasma than the Bh variant (Wu & Windmueller, 1981; Sparks & Marsh, 1981 (Sparks & Marsh, 1981) , our results suggest that this distinction must be at the level of the B/E receptor or a hitherto uncharacterized receptor.
Although the presence of apoprotein B1 on chylomicron remnants is not required for their uptake by the liver, the present results do not rule out a role for the apoprotein Bh variant modulating the efficiency with which apoprotein E binds to its receptors. Such a role could explain the more extended half-life in the circulation of lipoproteins containing the apoprotein Bh variant. It is noteworthy, however, that the residence time in the circulation of apoprotein B1 of intestinal origin is shorter than that of the apoprotein B1 of hepatic origin (Wu & Windmueller, 1981) . It seems that the interaction of the remnants of VLD lipoproteins with hepatic cell-surface receptors involves a primary recognition of apoprotein E and/or B with uptake being modulated by a variety of other components of these remnants. The nature of these complex modulations remains to be elucidated.
